/
/
ASH 2021: Making Sense of Newest Breakthroughs - Meet Vicki Jones
ASH 2021: Making Sense of Newest Breakthroughs - Meet Vicki Jones image
ASH 2021: Making Sense of Newest Breakthroughs - Meet Vicki Jones
Posted Dec 06, 2021

After her diagnosis in 2004, Vicki read everything she could get her hands on about myeloma, cancer, diet and alternative treatments.  “Since then” she says  “I’ve continued to try to be as knowledgable as possible and keep up with the wealth of information that’s become available.”

With more than 17 years and a veteran of treatments that include VAD, thalidomide, Velcade, a stem cell transplant, Revlimid, Kyprolis, Ninlaro, Darzalex and Blenrep, Vicki knows a thing or two about being a patient.

“You can do this!” she tells her patients.  “Every myeloma patient has to learn to cope with this beastly disease their own way. But I’ve found that having someone who’s been through it to talk to, compare notes with  and ask questions of, makes all the difference in the world.”  And that’s why she became a Myeloma Coach.

As ASH approaches, Vicki is most interested in learning about “the newest breakthroughs in myeloma.”  But beyond that, her interest in how the microbiome and microenvironment affect the survival of myeloma cells as well as how patients are dealing with some new drug side effects, are at the top of her list for reporting back to patients during ASH.

When she’s not dividing her year between Spokane, Washington and Lake Havasu City, Arizona, Vicki looks forward to events like ASH.  Her being there will lessen your work load as you try to keep up with the latest in myeloma treatment.

The author Greg Brozeit

about the author
Greg Brozeit

Greg Brozeit has been engaged in myeloma patient advocacy since 1998. He began working with the Myeloma Crowd in 2015. Prior to that, he consulted with Dr. Bart Barlogie at the University of Arkansas after working with the International Myeloma Foundation for 15 years, where he inaugurated the public policy advocacy program, patient support group outreach and IMF Europe, organizing more than 100 physician and patient education programs. He earned his BA in political science from Loyola University in New Orleans and lives in northeast Ohio.

More Myeloma News Articles

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.

Thanks to our HealthTree Community for Myeloma Sponsors:

Genentech
Abbvie
Bristol Myers Squibb
Janssen Oncology
GSK

Follow Us

facebook instagram twitter youtube

Copyright © 2022 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

 https://www.guidestar.org/profile/45-5354811